文献速递头颈外科

学术隶属与手术量可预测接受手术的头颈癌患者生存

Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
PubMed 文献 · Laryngoscope · 2020-05-25

该回顾性研究纳入北卡罗来纳州39家医疗中心,评估学术隶属或手术量是否影响接受手术的HPV阴性头颈鳞癌患者的总生存期。结果显示,社区癌症中心和手术量前三分之一的中心5年OS显著更优,学术医院在晚期患者中生存获益更明显。

要点

  • 社区癌症中心治疗与更好的5年OS显著相关(HR 0.68)。
  • 手术量前三分之一的中心5年OS显著更优(HR 0.64)。
  • 学术医院对晚期患者的生存获益更明显(HR 0.60)。

核心结论

  • 在学术医院、社区癌症中心和手术量前三分之一的医院治疗的HPV阴性HNSCC患者生存更有利。
  • 学术医院的生存获益在晚期患者中最为明显。

研究设计与样本

  • 回顾性研究,纳入北卡罗来纳州39家医疗中心。
  • 治疗中心分为学术医院、社区癌症中心或社区医院,并按手术量三分位分组。
  • 主要结局为5年OS,采用Cox比例风险模型校正人口学、肿瘤部位、分期、保险、吸烟、饮酒、化疗和放疗。
  • 患者按早期和晚期分层分析。

主要发现

  • 与社区医院相比,社区癌症中心5年OS显著更好(HR 0.68,95%CI 0.48-0.98)。
  • 学术医院5年OS有更好趋势(HR 0.72,95%CI 0.50-1.04)。
  • 学术隶属对晚期患者生存影响更明显(HR 0.60,95%CI 0.37-0.95)。
  • 早期患者不同治疗中心类型间无显著生存差异。
  • 手术量前三分之一中心5年OS显著更好(HR 0.64,95%CI 0.42-0.96),中间三分之一有更好趋势(HR 0.71,95%CI 0.51-1.03)。

临床怎么用

  • 对于HPV阴性HNSCC手术患者,可优先考虑社区癌症中心或高手术量中心。
  • 晚期患者可能从学术医院治疗中获益更多。

局限性

  • 证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether the academic affiliation or surgical volume affects the overall survival (OS) of human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) patients receiving surgery. METHODS: A retrospective study of 39 North Carolina Medical Centers was conducted. Treatment centers were classified as academic hospitals, community cancer centers, or community hospitals and were divided into thirds by volume. The primary outcome was 5-year OS. Hazard ratios (HR) were determined using Cox proportional hazard models, adjusting for demographics, tumor site, stage, insurance status, tobacco use, alcohol use, stage, chemotherapy, and radiation therapy. Patients were also stratified by stage (early stage and advanced stage). RESULTS: Patients treated at community cancer centers had significantly better 5-year OS (HR 0.68, 95% confidence interval [CI] = 0.48-0.98), and patients treated at academic hospitals trended toward better 5-year OS (HR 0.72, 95% CI = 0.50-1.04) compared to patients treated at community hospitals. The effect for academic affiliation on survival was more pronounced for patients with advanced stage cancer at diagnosis (HR 0.60, 95% CI = 0.37-0.95). There were no significant survival differences among early stage patients by treatment center type. Top-third (HR = 0.64, 95% CI = 0.42-0.96) centers by surgical volume had significantly better 5-year OS, and middle-third (HR = 0.71, 95% CI = 0.51-1.03) centers by volume trended toward better 5-year OS when compared to the bottom-third centers by volume. CONCLUSION: Patients treated at academic hospitals, community cancer centers, and hospitals in the top third by case volume have favorable survival for HPV-negative HNSCC. The effect for academic hospitals is most pronounced among advanced stage patients. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E479-E488, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Farquhar DR, Masood MM, Lenze NR, et al. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery. Laryngoscope. 2020. PMID: 32449832. doi:10.1002/lary.28744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。